We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Water Vapor Therapy Offers Alterative to Surgery or Radiation for Treating Prostate Cancer

By HospiMedica International staff writers
Posted on 08 Jan 2025

Intermediate-risk prostate cancer, in which the tumor remains confined to the prostate gland and does not spread to other organs, makes up about one-third of all localized prostate cancers. More...

Some individuals with prostate cancer may not require treatment if the tumor is small and slow-growing. However, when treatment is necessary, the standard approach has been surgery or radiation. While these methods are generally effective in treating the cancer, they can also lead to side effects. The prostate is located between the bladder, the urethra (a duct that carries urine from the bladder), and the rectum. It is surrounded by nerves responsible for penile erections and the muscle that controls urine flow, the urinary sphincter. During surgery or radiation, there is a risk of damaging healthy tissue along with the cancer and affecting the delicate structures adjacent to the prostate. The most common side effects of these treatments include impotence, urinary incontinence, and bowel dysfunction. Increasing research suggests that some patients may benefit from a procedure with fewer risks that enables them to maintain a higher quality of life post-treatment.

Steam offers a precise way to deliver heat into the body. Keck Medicine of USC (Los Angeles, CA, USA) is now involved in a U.S.-based, multisite clinical trial to determine whether a water vapor system, which uses small, targeted amounts of steam to destroy cancer cells, is a safe and effective treatment for prostate cancer. Researchers believe that steam may provide a less invasive option for managing or curing cancer compared to current methods. The study is sponsored by Francis Medical (Maple Grove, MN, USA), which developed the Vanquish Water Vapor Ablation System used in the trial. This water vapor ablation system is one of several minimally invasive treatments for prostate cancer that are either currently in use or under development in the field of urology.

Before the procedure, physicians use magnetic resonance imaging (MRI) to locate the tumor cells within the patient's prostate. During the procedure, doctors use ultrasound and prostate mapping to guide a thin catheter through the patient’s urethra into the prostate area containing the tumor. Once the catheter is properly positioned, a fine needle is deployed into the tumor. Doctors then release a brief, targeted 10-second burst of steam from the needle, with additional bursts as needed, to destroy the tumor. This method is believed to be gentler on the body than traditional therapies and is designed to focus on the cancerous tissue within the prostate. Researchers are investigating whether steam can effectively destroy cancer cells without damaging surrounding organs. Another potential benefit of this investigational therapy is that, unlike surgery, which requires an overnight hospital stay, the water vapor therapy is an outpatient procedure. Furthermore, unlike radiation, which typically requires multiple sessions, this water vapor therapy is designed to be effective with just one application.

“The most common therapies for prostate cancer often cause life-altering side effects, and we are investigating if this new treatment may not only treat the cancer, but offer our patients overall better quality-of-life outcomes,” said Andre Abreu, MD, a Keck Medicine urologist and lead investigator of the Keck Medicine clinical trial site. “Over the next decade or so, we hope to see innovative therapies revolutionize how we help patients become cancer-free while maintaining their quality of life.”

Related Links:
Francis Medical 


Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.